申请人:El Sayed Khalid A.
公开号:US20130165435A1
公开(公告)日:2013-06-27
Compositions of matter including (R)-2,5,6,8-tetramethyl-8-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)-1,2,3,8,9,10-hexahydrochromeno[5,6-e][1,3]oxazine and (R)-2,6,8-trimethyl-8-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)-1,2,3,8,9,10-hexahydrochromeno[5,6-e][1,3]oxazine are disclosed herein. Further disclosed are methods of preparation of such compounds and the use of such compounds as anticancer agents.
本文披露了包括(R)-2,5,6,8-四甲基-8-((3E,7E)-4,8,12-三甲基十三碳三烯基)-1,2,3,8,9,10-六氢色烯[5,6-e][1,3]噁唑和(R)-2,6,8-三甲基-8-((3E,7E)-4,8,12-三甲基十三碳三烯基)-1,2,3,8,9,10-六氢色烯[5,6-e][1,3]噁唑等物质的组合物。还披露了制备这些化合物的方法以及将这些化合物用作抗癌剂的用途。